See important information in relation to COVID-19 and our services here

Hydroxychloroquine Retinopathy

Freedom of information request details

FOI request date:

Service: Claims Management

The following information was requested:

I …am undertaking a piece of work on establishing hydroxychloroquine retinopathy monitory services across our ICS. One of the major barriers is the additional cost that the new service will add into the system and I am trying to find some data to demonstrate the benefit. I am anecdotally aware of rheumatologists who have received letters of complaint from patients who have lost some of their sight as a result of taking the drug without adequate monitoring of their eyes, and wondered whether NHS Resolution had any data on the costs of compensation claims for visual impairment caused by hydroxychloroquine retinopathy

Page last updated on: